New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
The DOI matches its Crossref record; 127 of the 128 references it cites were found in a registry or an index.
Abstract
Poly(ADP-ribose) polymerases (PARPs) are enzymes that transfer ADP-ribose groups to target proteins and thereby affect various nuclear and cytoplasmic processes. The activity of PARP family members, such as PARP1 and PARP2, is tied to cellular signalling pathways, and through poly(ADP-ribosyl)ation (PARylation) they ultimately promote changes in gene expression, RNA and protein abundance, and the location and activity of proteins that mediate signalling responses. PARPs act in a complex response network that is driven by the cellular, molecular and chemical biology of poly(ADP-ribose) (PAR). This PAR-dependent response network is crucial for a broad array of physiological and pathological responses and thus is a good target for chemical therapeutics for several diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated PARP1 will consume NAD+, generating PAR through a process called PARylation82.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [82]
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
Poly(ADP-ribose): novel functions for an old molecule
Schreiber, V., Dantzer, F., Ame, J.-C., & de Murcia, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1963 · Cited by 1,915
Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
Yu, S.-W., Wang, H., Poitras, M. F., Coombs, C., Bowers, W. J., Federoff, H. J., Poirier, G. G., Dawson, T. M., & Dawson, V. L. (2002) · Science · doi:10.1126/science.1072221 · Cited by 1,826
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
d'AMOURS, D., DESNOYERS, S., d'SILVA, I., & POIRIER, G. G. (1999) · Biochemical Journal · doi:10.1042/bj3420249 · Cited by 1,815
PARP inhibition: PARP1 and beyond
Rouleau, M., Patel, A., Hendzel, M. J., Kaufmann, S. H., & Poirier, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2812 · Cited by 1,298
Gelmon, K. A., Tischkowitz, M., Mackay, H., Swenerton, K., Robidoux, A., Tonkin, K., Hirte, H., Huntsman, D., Clemons, M., Gilks, B., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70214-5 · Cited by 1,117
Tankyrase, a Poly(ADP-Ribose) Polymerase at Human Telomeres
Smith, S., Giriat, I., Schmitt, A., & de Lange, T. (1998) · Science · doi:10.1126/science.282.5393.1484 · Cited by 1,012
Cited by
Items 601–700 of 1,000
En Guard! The Interactions between Adenoviruses and the DNA Damage Response
Kleinberger, T. (2020) · Viruses · doi:10.3390/v12090996 · Cited by 23
“Additional mechanisms are also utilized to enhance PARP-1 activation, including interactions with protein partners and various posttranslational modifications [24,27,28].”
BackgroundNanoparticle Formulations of Poly (ADP-ribose) Polymerase Inhibitors for Cancer Therapy
Singh, B., Yang, S., Krishna, A., & Sridhar, S. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.594619 · Cited by 27
Filippi, L., Frantellizzi, V., Chiaravalloti, A., Pontico, M., Feo, M. S. D., Corica, F., Montebello, M., Schillaci, O., VINCENTIS, G. D., & Bagni, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063036 · Cited by 22
“Interaction with damaged DNA activates poly-ADPribosylation reaction that is a reversible post-translational modification of proteins resulting in the covalent attachment of a polymer of ADP-ribose units on a variety of amino acids residues on target proteins [90].”
BackgroundPinkerton, A. B., Sessions, E. H., Hershberger, P., Maloney, P., Peddibhotla, S., Hopf, M. E., Sergienko, E. A., Ma, C.-T., Smith, L. H., Jackson, M. R., et al. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128007 · Cited by 22
Association of ATM activation and DNA repair with induced radioresistance after low-dose irradiation
Enns, L., Rasouli‐Nia, A., Hendzel, M. J., Marples, B., & Weinfeld, M. (2015) · Radiation Protection Dosimetry · doi:10.1093/rpd/ncv203 · Cited by 22
Recruitment of ubiquitin-activating enzyme UBA1 to DNA by poly(ADP-ribose) promotes ATR signalling
Kumbhar, R., Vidal-Eychenié, S., Kontopoulos, D. ‐. G., Larroque, M., Larroque, C., Basbous, J., Κοσσίδα, Σ., Ribeyre, C., & Constantinou, A. (2018) · Life Science Alliance · doi:10.26508/lsa.201800096 · Cited by 22
“C), which binds to and is activated by discontinuous DNA structures (Gibson & Kraus, 2012).”
BackgroundHuang, X., LeDuc, R. D., Fornelli, L., Schunter, A. J., Bennett, R. L., Kelleher, N. L., & Licht, J. D. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006159 · Cited by 23
“PARP1 is a nuclear DNA-dependent ADP-ribosyltransferase that catalyzes poly(ADP-ribosyl)ation (PAR) of nuclear proteins (29).”
BackgroundNew factors in mammalian DNA repair—the chromatin connection
Raschellà, G., Melino, G., & Malewicz, M. (2017) · Oncogene · doi:10.1038/onc.2017.60 · Cited by 26
Fu, W., Yao, H., Bütepage, M., Zhao, Q., Lüscher, B., & Li, J. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.05.007 · Cited by 21
Hutin, D., Long, A. S., Sugamori, K. S., Shao, P., Singh, S. K., Rasmussen, M., Olafsen, N. E., Pettersen, S., Grimaldi, G., Grant, D. M., et al. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab075 · Cited by 21
“PARPs are activated in response to internal and external cellular stresses, such as viral infection, genotoxicity, reactive oxygen species, and chemical toxicity (Cohen and Chang, 2018; Gibson and Kraus, 2012; Grunewald et al., 2020; Kraus and Hottiger, 2013).”
BackgroundUnconventional metabolites in chromatin regulation
Gapa, L., Alfardus, H., & Fischle, W. (2022) · Bioscience Reports · doi:10.1042/bsr20211558 · Cited by 29
Valdez, B. C., Nieto, Y. L., Yuan, B., Murray, D. L., & Andersson, B. S. (2022) · Oncotarget · doi:10.18632/oncotarget.28278 · Cited by 22
“Depletion of PARP1 using shRNA resulted in abrogation of protein PARylation, suggesting that PARP1 is the major enzyme that catalyzes PARylation, consistent with previous reports [31].”
ResultComprehensive machine learning boosts structure-based virtual screening for PARP1 inhibitors
Caba, K., Tran‐Nguyen, V., Rahman, T., & Ballester, P. J. (2024) · Journal of Cheminformatics · doi:10.1186/s13321-024-00832-1 · Cited by 26
“Furthermore, PARP1 has also been found to play a role in transcriptional regulation, chromosome stability, cell division, differentiation, apoptosis, and has been considered the most actively-pursued target for treating some cancers [6].”
BackgroundWu, Z., Wang, C., Bai, M., Li, X., Mei, Q., Li, X., Wang, Y., Fu, X., Luo, G., & Han, W. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv161 · Cited by 22
The Adenovirus E4orf4 Protein Provides a Novel Mechanism for Inhibition of the DNA Damage Response
Brestovitsky, A., Nebenzahl-Sharon, K., Kechker, P., Sharf, R., & Kleinberger, T. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005420 · Cited by 24
“Potential examples of E4orf4-PP2A targets that could affect both ATM- and ATR-regulated pathways include the MRN complex which accumulates at DNA damage foci and initiates signaling involving activation of ATM and ATR kinases [6, 8, 75], PARP-1 which interacts with both ATM and ATR and parylates them [76, 77], or othe…”
BackgroundHydroquinone induces TK6 cell growth arrest and apoptosis through PARP‐1/p53 regulatory pathway
Luo, H., Liang, H., Chen, J., Xu, Y., Chen, Y., Xu, L., Lin, Y., Liu, J., Yang, H., Liu, L., et al. (2017) · Environmental Toxicology · doi:10.1002/tox.22429 · Cited by 21
“1 is involved in various cellular processes including transcriptional regulation and DNA repair.(1,2) PARP-1 catalyzes the formation of ADPribosepolymers from nicotinamide adenine dinucleotide (NAD(1)) molecules at the locus of DNA strand breaks.”
BackgroundЛитвинко, Н. М., Скоростецкая, Л. А., & Герловский, Д. О. (2017) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2017.10.010 · Cited by 21
“…bilirubin, albumin (Peng et al., 2012)); The third group is those that remove oxidized lipids or repair cellular structures damaged by free oxygen radicals (phospholipase, DNA reduction enzymes (Gibson and Kraus, 2012; Hazra et al., 2001), methionine-sulfoxide reductase (Berlett and Levine, 2014)).”
BackgroundThe Modified Phenanthridine PJ34 Unveils an Exclusive Cell-Death Mechanism in Human Cancer Cells
Cohen‐Armon, M. (2020) · Cancers · doi:10.3390/cancers12061628 · Cited by 23
Peng, S., Shen, L., Tian, M., Li, H., & Wang, S. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9566 · Cited by 24
Branching of poly(ADP-ribose): Synthesis of the Core Motif
Kistemaker, H. A. V., Overkleeft, H. S., van der Marel, G. A., & Filippov, D. V. (2015) · Organic Letters · doi:10.1021/acs.orglett.5b02143 · Cited by 21
ADP-Ribosylated Peptide Enrichment and Site Identification: The Phosphodiesterase-Based Method
Daniels, C. M., Ong, S., & Leung, A. K. L. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6993-7_7 · Cited by 23
“Protein poly(ADP-ribosyl)ation (PARylation) and mono(ADPribosyl)ation (MARylation)—collectively, ADP-ribosylation—are increasingly being recognized for the important roles they play in cellular biology as traditional protein modifiers (in which their addition to a protein directly affects the protein’s structure or fu…”
Gottlieb, C. D., Thompson, A. C. S., Ordureau, A., Harper, J. W., & Kopito, R. R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009654 · Cited by 23
“Whereas many PARP proteins are active in stress-response pathways (20), the relationship of PARP4 and potentially vault-associated PARP4 to the PN remains unknown.”
BackgroundMitochondria as Regulators of Nonapoptotic Cell Death in Cancer
Malla, S., Neupane, R., Sood, S., Hussein, N. A., Abou-Dahech, M. S., Terrero, D., Ashby, C. R., Babu, R. J., & Tiwari, A. K. (2025) · MedComm · doi:10.1002/mco2.70244 · Cited by 25
PARylation of BRCA1 limits DNA break resection through BRCA2 and EXO1
Lodovichi, S., Quadri, R., Sertic, S., & Pellicioli, A. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112060 · Cited by 20
Chen, W., Qiukai, E., Sun, B., Zhang, P., Li, N., Fei, S., Wang, Y., Liu, S., Liu, X., & Zhang, X. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05984-w · Cited by 21
“In consistence with these fi ndings, our results showing that inhibition or depletion of PARP1 in GCs arrested GC proliferation and differentiation and led to the failure of primordial follicle activation may help establish PARP1 as a novel pivotal regulator in GCs in dominating the selection of…”
Carter-O’Connell, I., & Cohen, M. S. (2015) · Current Protocols in Chemical Biology · doi:10.1002/9780470559277.ch140259 · Cited by 20
“PARP1 plays an important role in the singlestranded DNA break repair pathway (Burkle, 2006; Gibson and Kraus, 2012).”
BackgroundMartínez‐Bosch, N., Fernández-Zapico, M. E., Navarro, P., & Yélamos, J. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.09.021 · Cited by 20
Gibson, B. A., & Kraus, W. L. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6993-7_9 · Cited by 20
Self-citationAsthma and poly(ADP-ribose) polymerase inhibition: a new therapeutic approach
Zaffini, R., Gotte, G., & Menegazzi, M. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s150846 · Cited by 24
“22 PARylation is a transient protein modification, as the polymer is rapidly split into ADP-ribose monomers and polymers by a poly(ADP-ribose) glycohydrolase.”
Keppler, B. D., Song, J., Nyman, J., Voigt, C. A., & Bent, A. F. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.01907 · Cited by 20
“Poly(ADP-ribosyl)ation is a post-translational modification of proteins in which chains of ADP-ribose are added to a target protein by enzymes known as poly-ADP-ribose polymerases (PARPs) (Gibson and Kraus, 2012).”
BackgroundLi, P., Zhen, Y., & Yu, Y. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.06.024 · Cited by 20
Specific Binding of snoRNAs to PARP‑1 Promotes NAD+‑Dependent Catalytic Activation
Huang, D., Kim, D.-S., & Kraus, W. L. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00100 · Cited by 20
Self-citationPARP inhibition in treatment of pancreatic cancer
Hammel, P. R., Zhang, C., Matile, J., Colle, E., Hadj-Naceur, I., Gagaille, M.-P., Bouattour, M., Cros, J. F., de Mestier, L., & Lamuraglia, M. (2020) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2020.1820330 · Cited by 20
D’Errico, M., Parlanti, E., Pascucci, B., Filomeni, G., Mastroberardino, P. G., & Dogliotti, E. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108977 · Cited by 20
Gajan, A., Sarma, A., Kim, S., Gurdziel, K., Wu, G. S., & Shekhar, M. P. V. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.694793 · Cited by 21
“Among the 18 PARP family members, PARP-1 is the principal responder to DNA damage as it rapidly reaches the target damage site and mounts a robust catalytic activation response that influences cellular outcomes to the damage (4, 5).”
BackgroundProfiling of the ADP‐Ribosylome in Living Cells
Lehner, M., Rieth, S., Höllmüller, E., Spliesgar, D., Mertes, B., Stengel, F., & Marx, A. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202200977 · Cited by 20
Zhai, L., Li, S., Li, H., Zheng, Y., Lang, R., Fan, Y., Gu, F., Guo, X., Zhang, X., & Fu, L. (2015) · Europe PMC (PubMed Central) · Cited by 25
Identifying and Validating Tankyrase Binders and Substrates: A Candidate Approach
Pollock, K., Ranes, M., Collins, I., & Guettler, S. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6993-7_28 · Cited by 20
“Poly(ADP-ribosyl)ation (PARylation) constitutes a striking posttranslational modification (PTM) catalyzed by poly(ADP-ribose) polymerase (PARP) enzymes, which serially transfer ADP-ribose from NAD+ onto substrate proteins [1].”
BackgroundWang, Z., Xu, E., Wang, C., Wei, W., Liu, Y., & Liu, S. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.09.023 · Cited by 20
Dorothea, M., Xie, J., Yiu, S. P. T., & Chiang, A. (2023) · Cancers · doi:10.3390/cancers15072120 · Cited by 21
Lester, A., Rapkins, R. W., Nixdorf, S., Khasraw, M., & McDonald, K. L. (2016) · Clinical & Translational Oncology · doi:10.1007/s12094-016-1547-4 · Cited by 19
“These pADPr chains signal and attract repair proteins [2].”
BackgroundKlemm, T., Mannuß, A., Kobbe, D., Knoll, A., Trapp, O., Dorn, A., & Puchta, H. (2017) · The Plant Journal · doi:10.1111/tpj.13602 · Cited by 20
“RAD5A and PARP1 act in different pathways of base methylation repair PARPs catalyze the synthesis and transfer of poly ADPribose (PAR) to target proteins, and the mammalian ortholog of AtPARP1 is a prominent factor in SSB repair and BER (reviewed in Gibson and Kraus, 2012).”
BackgroundGenerating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro
Lin, K. Y., Huang, D., & Kraus, W. L. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8588-3_7 · Cited by 19
Self-citationBrysbaert, G., Mauri, T., de Ruyck, J., & Lensink, M. F. (2018) · Current Protocols in Bioinformatics · doi:10.1002/cpbi.66 · Cited by 19
“The poly[ADP-ribose]polymerase 1 transfers ADP-ribose groups to target proteins and is involved in the regulation of many cellular processes like cell division, transcriptional regulation, or DNA damage response (Gibson & Kraus, 2012).”
BackgroundAssessment of PARP4 as a candidate breast cancer susceptibility gene
Prawira, A., Munusamy, P., Yuan, J., Chan, C. H. T., Koh, G. L., Shuen, T. W. H., Hu, J., Yap, Y. S., Tan, M. H., Ang, P., et al. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05286-w · Cited by 23
NAD+-targeting by bacteria: an emerging weapon in pathogenesis
Roussin, M., & Salcedo, S. P. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab037 · Cited by 19
Kyo, S., Kanno, K., Takakura, M., Yamashita, H., Ishikawa, M., Ishibashi, T., Sato, S., & Nakayama, K. (2022) · Cancers · doi:10.3390/cancers14102504 · Cited by 22
“It binds to the sites of SSBs via the zinc-finger DNA binding domains and catalyzes poly-ADPribosylation (PARylation) to proteins that repair SSBs using their enzymatic activity [9,10].”
BackgroundPoly(ADP-ribosylation) and neurodegenerative disorders
Basello, D. A., & Scovassi, A. I. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.07.005 · Cited by 21
“Poly(ADPribosylation) is carried on by poly(ADP-ribose) polymerases (PARPs), belonging to the superfamily of enzymes able to synthesize ADPribose (ADPR) (Gibson and Kraus, 2012; Hassa and Hottiger, 2008).”
BackgroundLiang, Y., Hsu, C.-Y., Yao, Y.-L., & Yang, W. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.092 · Cited by 22
“In PARylation, the ADP-ribose moiety of donor NAD molecule is transferred to acceptor proteins, resulting in functional changes [2].”
BackgroundKim, H., Ham, S., Lee, J. Y., Jo, A., Lee, G. H., Lee, Y., Cho, M., Shin, H., Kim, D., Pletniková, O., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21828 · Cited by 20
“This regulation depends on the cellular context, which determines the roles of PARP1 and its substrates [8, 10].”
BackgroundLi, R., Luo, R., Luo, Y., Hou, Y., Wang, J., Zhang, Q., Chen, X., Hu, L., & Zhou, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1093939 · Cited by 20
“Gibson and Kraus (21) suggested that PARP1 synthesized by PARP1 in the nucleus could serve as a scaffold for DNA repair and recruit DNA repair proteins to the damaged site.”
BackgroundADP-Ribosylation in Antiviral Innate Immune Response
Du, Q., Miao, Y., He, W., & Zheng, H. (2023) · Pathogens · doi:10.3390/pathogens12020303 · Cited by 21
“ARTs transfer one or more ADPribose (ADPr) units from nicotinamide adenine dinucleotide (NAD+) to target proteins on a variety of amino acids, including lysine (Lys), arginine (Arg), glutamate (Glu), aspartate (Asp), and cysteine (Cys) [6], leading to mono-ADP-ribosylation (MARylation) or polyADP-ribosylation (PARylat…”
The Potential of PARP Inhibitors as Antitumor Drugs and the Perspective of Molecular Design
Wang, Y., Zhang, J., Wu, X., Huang, L., Xiao, W., & Guo, C. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02642 · Cited by 18
Exploring the effect of PARP-1 flexibility in docking studies
Antolín, A. A., Carotti, A., Nuti, R., Hakkaya, A., Camaioni, E., Mestres, J., Pellicciari, R., & Macchiarulo, A. (2013) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2013.08.006 · Cited by 18
Tcherniuk, S. O., Chesnokova, O. N., Oleinikov, I. V., & Oleinikov, A. V. (2017) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2017.06.004 · Cited by 18
“The nicotinamide action through the inhibition of DNA repair enzyme poly-ADP-ribose polymerase (PARP) [42], ADP-ribose-transferase (ART) [43], cyclic ADP ribose hydrolase (CD38) [44] and sirtuin deacetylases [20-22] can explain the versatile effects of this compound.”
BackgroundSUMOylation of XRCC1 activated by poly (ADP-ribosyl)ation regulates DNA repair
Hu, L.-Y., Chang, C., Huang, Y., Chou, W., Lin, Y.-M., Ho, C.-C., Chen, W.-T., Shih, H.-M., Hsiung, C.-N., Wu, P.-E., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy135 · Cited by 18
Partnering with PARP inhibitors in acute myeloid leukemia with FLT3-ITD
Dellomo, A. J., Baer, M. R., & Rassool, F. V. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.048 · Cited by 19
Signal-induced PARP1-Erk synergism mediates IEG expression
Cohen‐Armon, M., Yeheskel, A., & Pascal, J. M. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0042-0 · Cited by 21
PARP Inhibitors in Prostate and Urothelial Cancers
Garje, R., Vaddepally, R. K., & Zakharia, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00114 · Cited by 18
“PARP-1 functions as a transcription modulator and regulates the oncogenes, tumor suppressor genes, and inflammatory genes involved in chromatin modulation and gene transcription (14, 15).”
BackgroundKaiser, A., Krüger, T., Eiselt, G., Bechler, J., Kniemeyer, O., Huber, O., & Schmidt, M. (2020) · Cells · doi:10.3390/cells9020427 · Cited by 18
“It recognizes various substrate proteins via different binding motives [12] and is involved in cellular processes related to DNA methylation, the regulation of splicing, chromatin modulation, DNA repair and transcriptional co-regulation such as histone modifications.”
BackgroundThakur, A., Rana, M., Ritika, Mathew, J., Nepali, S., Pan, C.-H., Liou, J. P., & Nepali, K. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106893 · Cited by 18
Marchand, J., Carotti, A., Passeri, D., Filipponi, P., Liscio, P., Camaioni, E., Pellicciari, R., Gioiello, A., & Macchiarulo, A. (2014) · Biochimica et Biophysica Acta · doi:10.1016/j.bbapap.2014.07.012 · Cited by 18
“Poly (ADP-ribose) polymerases (PARPs) are a family of posttranscriptional regulatory enzymes that use nicotinamide adenine dinucleotide (NAD) as substrate to transfer ADP-ribose moieties to target proteins [1,2].”
BackgroundAlleles of newly identified barley gene HvPARP3 exhibit changes in efficiency of DNA repair
Stolarek-Januszkiewicz, M., Gruszka, D., Brąszewska-Zalewska, A., & Małuszyński, M. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.02.018 · Cited by 20
The role of ADP-ribosylation in regulating DNA interstrand crosslink repair
Gunn, A. R., Baños-Piñero, B., Paschke, P., Sánchez‐Pulido, L., Ariza, A., Day, J. P., Emrich, M., Leys, D., Ponting, C. P., Ahel, I., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.193375 · Cited by 21
“, 2012), in addition to those of others in vertebrates (Gibson and Kraus, 2012), implicate ARTs in repair of SSBs and DSBs.”
BackgroundResultInfluentialPARP-1 may be involved in hydroquinone-induced apoptosis by poly ADP-ribosylation of ZO-2
Liu, J., Yuan, Q., Ling, X., Tan, Q., Liang, H., Chen, J., Lin, L., Xiao, Y., Chen, W. L., Liu, L., et al. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7643 · Cited by 18
“…(PARylation), a type of reversible protein modification, is performed by the enzymes in the PARP family and poly(ADP-ribose) (PAR)-degrading enzymes, such as PAR glycohydrolase (3), ADP-ribosyl hydrolase 3 (4) and members of the nucleoside diphosphate linked moiety X family of proteins (5).”
PARP1 is required for preserving telomeric integrity but is dispensable for A-NHEJ
Harvey, A., Mielke, N., Grimstead, J. W., Jones, R. E., Nguyen, T., Mueller, M. R., Baird, D. M., & Hendrickson, E. A. (2018) · Oncotarget · doi:10.18632/oncotarget.26201 · Cited by 18
“To date there has been little phenotypic characterization of the genetic knockout of PARP1 in human somatic cells, as the field has either relied on RNAi knockdowns, or, primarily, by utilizing one of the many inhibitors available to PARP1 [9, 10].”
BackgroundGagliardi, S., Hotchkin, T., Hillmer, G., Engelbride, M., Diggs, A., Tibebe, H., Izumi, C., Sullivan, C., Cropp, C., Lantz, O., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146724 · Cited by 18
Krug, S., Gupta, M., Kumar, P., Feller, L., Ihms, E. A., Kang, B. G., Srikrishna, G., Dawson, T. M., Dawson, V. L., & Bishai, W. R. (2023) · Nature Communications · doi:10.1038/s41467-023-43937-1 · Cited by 18
Jia, Y., Zhao, J., Wang, C., Meng, J., Zhao, L., Yang, H., & Zhao, X. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05069-y · Cited by 17
“PARP1 is the most characterized member of the PARPs, which uses NAD + as a cofactor to promote PARylation of other proteins, thereby controlling a range of different biological functions [35].”
BackgroundThe Discovery of a Potent PARP1 Inhibitor Senaparib
Cai, S. X., Ma, N., Wang, X., Guo, M., Jiang, Y., & Tian, Y. E. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0625 · Cited by 19
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy
Chen, C., Han, P., & Qing, Y. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103579 · Cited by 17
Liao, M., Long, X., Chen, Y., An, J., Huang, W., Xu, X., & Fan, Y. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03374-x · Cited by 19
“PARP9, a mono-ADP ribosyl transferase, is not involved in DNA repair [45] but has been linked to the regulation of apoptosis and inflammation in various disease models [21–24].”
Chemical reporters for exploring ADP-ribosylation and AMPylation at the host–pathogen interface
Westcott, N. P., & Hang, H. C. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.10.002 · Cited by 17
Irvine, K., Bishop, R. K., Won, S. J., Xu, J., Hamel, K. A., Coppes, V. G., Singh, P., Sondag, A., Rome, E., Basu, J., et al. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2017.5044 · Cited by 18
“10,11 14 Mammalian cells contain several PARP family members, of which PARP-1 is the major species.”
Slow Dissociation from the PARP1–HPF1 Complex Drives Inhibitor Potency
Stojanovic, P., Luger, K., & Rudolph, J. (2023) · Biochemistry · doi:10.1021/acs.biochem.3c00243 · Cited by 17
Tang, X., Hobbs, C. A., Cleves, M. A., Erickson, S. W., MacLeod, S. L., Malik, S., & Study, T. N. B. D. P. (2015) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23370 · Cited by 17
“Poly (ADP-ribose) polymerases (PARPs) are enzymes involved in various cytoplasmic and nuclear processes, including inflammation, mitochondrial metabolism, DNA damage repair, and transcriptional regulation (De Vos et al., 2012; Gibson and Kraus, 2012; Liang et al., 2013).”
Poly(ADP‐ribose) polymerases regulate cell division and development in Arabidopsis roots
Liu, C., Wu, Q. Y., Liu, W., Gu, Z., Wang, W., Xu, P., Mā, H., & Ge, X. (2017) · Journal of Integrative Plant Biology · doi:10.1111/jipb.12530 · Cited by 18
“They have been found to regulate many biological processes such as DNA repair, gene transcription, epigenetic regulation, stress response and cell death in animal systems (Gibson and Kraus 2012; Kalisch et al. 2012; Luo and Kraus 2012; Swindall et al. 2013; Leung 2014).”
BackgroundDNA Double Strand Break Repair - Related Synthetic Lethality
Toma, M. M., Skórski, T., & Śliwiński, T. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180201114306 · Cited by 18
Enhanced sensitivity to cholera toxin in female ADP-ribosylarginine hydrolase (ARH1)-deficient mice
Watanabe, K., Kato, J., Zhu, J., Oda, H., Ishiwata-Endo, H., & Moss, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207693 · Cited by 18
“poly-ADP-ribose-polymerase (PARP)1) [12].”
BackgroundNebenzahl-Sharon, K., Sharf, R., Amer, J., Shalata, H., Khoury-Haddad, H., Sohn, S., Ayoub, N., Hearing, P., & Kleinberger, T. (2019) · Journal of Virology · doi:10.1128/jvi.02253-18 · Cited by 17
Garcia, C. S., Garcia, P. R., Espíndola, C. N. D. S., Nunes, G. D., Jardim, N. S., Müller, S. G., Bortolatto, C. F., & Brüning, C. A. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02483-x · Cited by 17
“PARP also activates pro-inflammatory gene expression, through the promotion of MAP kinases and NF-κB [55].”
BackgroundInfluentialParp‐1 genetic ablation in Ela–myc mice unveils novel roles for Parp‐1 in pancreatic cancer
Martínez‐Bosch, N., Iglesias, M., Munné‐Collado, J., Martínez, C. M., Moreno, M., Guerra, C. E., Yélamos, J., & Navarro, P. (2014) · The Journal of Pathology · doi:10.1002/path.4384 · Cited by 20
“Parp-1 is the major protein responsible for cellular PARylation activity, and Parp-1 functions are mediated by its physical association with or by the PARylation of its partner proteins, which are involved mainly in chromatin structure and/or DNA metabolism [11,12].”
BackgroundOncohistone Mutations Occur at Functional Sites of Regulatory ADP-Ribosylation
Huang, D., Camacho, C. V., Martire, S., Nagari, A., Setlem, R., Gong, X., Edwards, A. D., Chiu, S.-P., Banaszynski, L. A., & Kraus, W. L. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0742 · Cited by 16
Self-citationA field guide to the proteomics of post‐translational modifications in DNA repair
Sanford, E. J., & Smolka, M. B. (2022) · PROTEOMICS · doi:10.1002/pmic.202200064 · Cited by 17
Feldmann, J., Li, Y., & Tor, Y. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201805520 · Cited by 16
Abdulrahman, N., Siveen, K. S., Joseph, J. M., Osman, A., Yalcin, H. C., Hasan, A., Shahab Uddin, M. S., & Mraiche, F. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13335 · Cited by 16
“cellular processes such as DNA repair, cell death, chromatin functions and genomic stability.([26,27]) During apoptosis, PARP was the first protein to be identified to be cleaved and results in the formation of two polypeptides of 89 and 24 kDa.”
BackgroundCommon Mechanism for Target Specificity of Protein- and DNA-Targeting ADP-Ribosyltransferases
Yoshida, T., & Tsuge, H. (2021) · Toxins · doi:10.3390/toxins13010040 · Cited by 16
“The poly(ADP-ribose) polymerase (PARP) family comprises 17 members: PARP1 to PARP16, which includes two tankyrases (PARP5a and PARP5b) [41,42].”
BackgroundGupte, R., Lin, K. Y., Nandu, T. S., Lea, J. S., & Kraus, W. L. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0111 · Cited by 16
Self-citationKhadka, P., Hsu, J. K., Veith, S., Tadokoro, T., Shamanna, R. A., Mangerich, A., Croteau, D. L., & Bohr, V. A. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00427-15 · Cited by 17
“PARP1 is the most ubiquitously expressed PARP family member and constitutes the majority of PAR synthesis in human cells (3, 4).”
BackgroundKumar, C., Rani, N., Lakshmi, P. T. V., & Annamalai, A. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0113 · Cited by 18
Antidepressant-Like Actions of Inhibitors of Poly(ADP-Ribose) Polymerase in Rodent Models
Ordway, G. A., Szebeni, A., Hernandez, L. J., Crawford, J. D., Szebeni, K., Chandley, M. J., Burgess, K. C., Miller, C. A., Bakkalbasi, E., & Brown, R. W. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx068 · Cited by 20
“including DNA repair, chromatin remodeling, and activation of NF-κB (Gibson and Kraus, 2012).”
BackgroundInfluentialSuperfast DNA replication causes damage in cancer cells
Quinet, A., & Vindigni, A. (2018) · Nature · doi:10.1038/d41586-018-05501-6 · Cited by 16
Cho, C., Chien, C., Chiu, Y., Lin, M.-H., & Hsu, C. (2019) · Nature Communications · doi:10.1038/s41467-019-09153-6 · Cited by 16
RNF114 suppresses metastasis through regulation of PARP10 in cervical cancer cells
Zhao, Y., Liang, X., Wei, L., Liu, Y., Liu, J., Feng, H., Zheng, F., Wang, Y., Ma, H., & Wu, J. (2021) · 癌症:英文版 · doi:10.1002/cac2.12132 · Cited by 16
“Dear editor, ADP-ribosylation is a post-translational modification catalysed by poly(ADP-ribose) polymerases (PARPs) and plays important roles in diverse biological processes, such as DNA repair, chromatin remodelling, telomere homeostasis, transcription, chromosome segregation, cell proliferation, and cell death [1,…”
BackgroundSynthesis of Bispecific Antibody Conjugates Using Functionalized Poly-ADP-ribose Polymers
Cheng, Q., Zhang, X., Li, J., Chen, J., Wang, Y., & Zhang, Y. (2023) · Biochemistry · doi:10.1021/acs.biochem.2c00718 · Cited by 15
Li, Z., Luo, A., & Xie, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241915028 · Cited by 16
“Recruitment of DNA Repair Factors By promoting the recruitment of XRCC1 and ALC1 to the damage site via the ADPr of the target protein at the break, it modulates the assembly and turnover of additional factors that promote DNA repair [37].”
Dong, Y., Wang, X., Wei, L., Liu, Z., Chu, X., Xiong, W., Liu, W., & Li, X. (2024) · Antioxidants · doi:10.3390/antiox13040385 · Cited by 15
Shukla, N., Shah, K., Rathore, D., Soni, K., Shah, J., Vora, H., & Dave, H. V. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122697 · Cited by 17
Coupling cellular drug-target engagement to downstream pharmacology with CeTEAM
Valerie, N. C. K., Sanjiv, K., Mortusewicz, O., Zhang, S. M., Alam, S., Pires, M. J., Stigsdotter, H., Rasti, A., Langelier, M.-F., Rehling, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54415-7 · Cited by 16
Lindgren, A. E. G., Karlberg, T., Ekblad, T., Spjut, S., Thorsell, A. G., Andersson, C. D., Nhan, T. T., Hellsten, V., Weigelt, J., Linusson, A., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401394u · Cited by 15
Metadata
- Authors
- Gibson, B. A., & Kraus, W. L.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Kraus, W. Lee
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2012-06-20
- Volume
- 13
- Issue
- 7
- Pages
- 411-424
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1965006127
- Cited by
- 1,226
- References
- 128
- Citations by year
- 2026: 58 · 2025: 79 · 2024: 76 · 2023: 84 · 2022: 94 · 2021: 113 · 2020: 108 · 2019: 83 · 2018: 97 · 2017: 94 · 2016: 86 · 2015: 91 · 2014: 77 · 2013: 79 · 2012: 7
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- poly(ADP-ribosyl)ation, poly(ADP-ribose), PARP1, PARP2, PARP family, protein modification, signal transduction, gene expression regulation, PARP inhibitors
- MeSH terms
- Animals, Catalysis, Cell Nucleus, Cherubism, Cytoplasm, Gene Expression Regulation, Humans, Models, Molecular, Poly Adenosine Diphosphate Ribose, Poly(ADP-ribose) Polymerases, Polymers, Protein Conformation, Protein Processing, Post-Translational, RNA, Signal Transduction, Protein Structure, Tertiary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.